Quick Answer
SELLAS Life Sciences Group, Inc. reported Stockholders Equity of $70.87 million for fiscal year 2025.
SELLAS Life Sciences Group, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $70.87M | +648.8% |
| 2024 | $9.46M | +218.7% |
| 2023 | -$7.98M | -264.4% |
| 2022 | $4.85M | -76.2% |
| 2021 | $20.35M | -27.2% |
| 2020 | $27.96M | +358.9% |
| 2019 | $6.09M | +16.2% |
| 2018 | $5.25M | +153.4% |
| 2017 | $2.07M | +141.4% |
| 2016 | -$5.00M | +59.2% |
| 2015 | -$12.26M | -133.1% |
| 2014 | $37.06M | +529.6% |
| 2013 | $5.89M | -78.8% |
| 2012 | $27.76M | +174.5% |
| 2011 | $10.11M | +316.1% |
| 2010 | $2.43M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $45.63M | +187.1% | +74.5% |
| June 30, 2025 | $26.15M | +797.7% | -5.8% |
| March 31, 2025 | $27.76M | +186.6% | +193.3% |
| December 31, 2024 | $9.46M | +218.7% | -40.4% |
| September 30, 2024 | $15.89M | +515.3% | +445.6% |
| June 30, 2024 | $2.91M | -39.9% | -69.9% |
| March 31, 2024 | $9.68M | -26.5% | +221.4% |
| December 31, 2023 | -$7.98M | -264.4% | -108.4% |
- SELLAS Life Sciences Group, Inc. showed an increase of +648.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2010–2025 period, SELLAS Life Sciences Group, Inc.’s stockholders equity has grown by 2816.5% (from $2.43 million to $70.87 million).
- The most recent figure is from SELLAS Life Sciences Group, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: